| 产品名称： | Recombinant Adeno-associated virus 8 |
|---|---|
| 商品货号： | TS185441 |
| Agent： | Recombinant Adeno-associated virus 8 |
| Strain： | Recombinant Adeno-associated Virus 8 Reference Standard Stock (rAAV8-RSS) |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 0.125 mL |
| Storage Conditions： | -80°C or colder |
| Comments： | For additional information on handling the Recombinant Adeno-associated Virus 8 Reference Standard Stock, view the AAVRSWG Handling Guide located on the ATCC website at www.atcc.org. |
| Growth Conditions： | For additional information on handling the Recombinant Adeno-associated Virus 8 Reference Standard Stock, view the AAVRSWG Handling Guide located on the ATCC website at www.atcc.org. |
| Name of Depositor： | Adeno-associated Virus Reference Standard Working Group (AAVRSWG) |
| References： | Ayuso E, et al. Reference materials for the characterization of adeno-associated viral vectors. In: Cohen-haguenauer, O (ed). The Clinibook: clinical gene transfer state of the art. EDK: Paris: pp. 83-90, 2012. Moullier P, Snyder RO. Recombinant adeno-associated viral vector reference standards. Methods Enzymol. 507: 297-311, 2012. PubMed: 22365780 Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008. Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177 Tessier J, et al. Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J. Virol. 75(1):375-383, 2001. PubMed: 11119606 Lock M, et al. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum. Gene Ther. 21(10): 1273-1285, 2010. PubMed: 20486768 Ayuso E, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 17(4): 503-510, 2010. PubMed: 19956269 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Recombinant Adeno-associated virus 8 |
|---|---|
| 商品货号： | TS185441 |
| Agent： | Recombinant Adeno-associated virus 8 |
| Strain： | Recombinant Adeno-associated Virus 8 Reference Standard Stock (rAAV8-RSS) |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 0.125 mL |
| Storage Conditions： | -80°C or colder |
| Comments： | For additional information on handling the Recombinant Adeno-associated Virus 8 Reference Standard Stock, view the AAVRSWG Handling Guide located on the ATCC website at www.atcc.org. |
| Growth Conditions： | For additional information on handling the Recombinant Adeno-associated Virus 8 Reference Standard Stock, view the AAVRSWG Handling Guide located on the ATCC website at www.atcc.org. |
| Name of Depositor： | Adeno-associated Virus Reference Standard Working Group (AAVRSWG) |
| References： | Ayuso E, et al. Reference materials for the characterization of adeno-associated viral vectors. In: Cohen-haguenauer, O (ed). The Clinibook: clinical gene transfer state of the art. EDK: Paris: pp. 83-90, 2012. Moullier P, Snyder RO. Recombinant adeno-associated viral vector reference standards. Methods Enzymol. 507: 297-311, 2012. PubMed: 22365780 Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008. Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177 Tessier J, et al. Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J. Virol. 75(1):375-383, 2001. PubMed: 11119606 Lock M, et al. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum. Gene Ther. 21(10): 1273-1285, 2010. PubMed: 20486768 Ayuso E, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 17(4): 503-510, 2010. PubMed: 19956269 |
